4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-23-002666
Chief Financial Officer sold 20,236 shares at an average $45.02 ($910,947)
- Chief Financial Officer acquired 20,236 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burrell Terry-Ann Chief Financial Officer | 2023-01-23 | Option exercise | +5,426 | $13.68 | $74,228 | 36,703 | D |
| Burrell Terry-Ann Chief Financial Officer | 2023-01-23 | Sale | −5,426 | $45.02 | $244,290 | 31,277 | D |
| Burrell Terry-Ann Chief Financial Officer | 2023-01-24 | Option exercise | +14,810 | $13.68 | $202,601 | 46,087 | D |
| Burrell Terry-Ann Chief Financial Officer | 2023-01-24 | Sale | −14,810 | $45.01 | $666,657 | 31,277 | D |
| Derivatives | |||||||
| Burrell Terry-Ann Chief Financial Officer | 2023-01-23 | Option exercise · Stock Option (Right to Buy) | −5,426 | 237,629 | D | ||
| Burrell Terry-Ann Chief Financial Officer | 2023-01-24 | Option exercise · Stock Option (Right to Buy) | −14,810 | 222,819 | D | ||
| Open-market sales · 20,236 sh · avg $45.02 · $910,947 | |||||||
Loading xslF345X03/doc4.xml…